bioworld.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# See http://www.robotstxt.org/wc/norobots.html for documentation on how to use the robots.txt file # # To ban all spiders from the entire site uncomment the next two lines: # User-agent: * # Disallow: / User-agent: * Crawl-delay: 10 Sitemap: https://www.bioworld.com/sitemap.xml Disallow: /comments/flag/ Disallow: /search Disallow: /articles/comment/abuse Disallow: /articles/email Disallow: /articles/preview Disallow: /articles/print Disallow: /products/email Disallow: /products/print Disallow: /cart Disallow: /user/* Disallow: /*/log_view Disallow: | ||
Meta Tags
| Title | BioWorld: The Daily Biopharmaceutical and Medical Technology News |
| Description | BioWorld. Link to Daily news and analysis of the global biotechnology, pharmaceutical and medical technology |
| Keywords | news, analysis, biotech, biotechnology, pharma, pharmaceutical, health, business, medtech, medical technology, devices, diagnostics, financing, regulation, science, innovation, drug approvals, FDA, EMA, clinical trials, partnerships |
Server Information
| WebSite | |
| Host IP | 208.91.60.34 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
bioworld.com Valuation
|
US$20,133,350
Last updated: 2023-04-27 08:45:38
bioworld.com has Semrush global rank of 525,710. bioworld.com has an estimated worth of US$ 20,133,350, based on its estimated Ads revenue. bioworld.com receives approximately 2,323,079 unique visitors each day. Its web server is located in United States, with IP address 208.91.60.34. According to SiteAdvisor, bioworld.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$20,133,350 |
| Daily Ads Revenue | US$18,585 |
| Monthly Ads Revenue | US$557,539 |
| Yearly Ads Revenue | US$6,690,467 |
| Daily Unique Visitors | 154,872 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| bioworld.com. | A | 300 | IP: 208.91.60.34 |
| bioworld.com. | NS | 86400 | NS Record: ha4.markmonitor.zone. |
| bioworld.com. | NS | 86400 | NS Record: ha1.markmonitor.zone. |
| bioworld.com. | NS | 86400 | NS Record: ha3.markmonitor.zone. |
| bioworld.com. | NS | 86400 | NS Record: ha2.markmonitor.zone. |
| bioworld.com. | MX | 86400 | MX Record: 10 mxb-0030e801.gslb.pphosted.com. |
| bioworld.com. | MX | 86400 | MX Record: 10 mxa-0030e801.gslb.pphosted.com. |
| bioworld.com. | TXT | 86400 | TXT Record: v=spf1 include:spf.protection.outlook.com include:spf-0030e801.pphosted.com include:servers.mcsv.net ip4:208.91.60.0/24 -all |
HtmlToTextCheckTime:2023-04-27 08:45:38
| All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser. More information on our cookie policy. BioWorld. Link to homepage. BioWorld BioWorld MedTech BioWorld Asia BioWorld Science Data Snapshots BioWorld BioWorld MedTech Special reports Aging Biosimilars Artificial intelligence Coronavirus IVDs on the rise Radiopharmaceuticals Science ’22 in Review Top Biopharma Trends of 2022 Top Med-tech Trends of 2022 Premium reports BioWorld Financings Reports Disease Incidence & Prevalence Summaries BioWorld. Link to homepage. sign in Sign Out My Account Subscribe BioWorld - Wednesday, April 26, 2023 BioWorld BioWorld MedTech BioWorld Asia BioWorld Science BioWorld Biogen’s ALS drug is approved, but there’s more to come Despite the approval of Biogen Inc.’s Qalsody (tofersen) for treating amyotrophic lateral sclerosis (ALS), there are still hurdles for the drug |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: http://www.bioworld.com/ Content-Type: text/html; charset=utf-8 Content-Length: 162 Accept-Ranges: bytes Date: Wed, 20 Oct 2021 13:56:51 GMT Age: 0 Via: 1.1 varnish Connection: keep-alive Vary: User-Agent X-Cache: MISS X-Frame-Options: SAMEORIGIN Allow-Ranges: bytes Content-Security-Policy: frame-ancestors 'self' continuum.epublishing.com *.continuum.epublishing.com HTTP/1.1 301 Moved Permanently Location: https://www.bioworld.com/ Content-Type: text/html; charset=utf-8 Content-Length: 0 Accept-Ranges: bytes Date: Wed, 20 Oct 2021 13:56:51 GMT Age: 183 Via: 1.1 varnish Connection: keep-alive Vary: User-Agent X-Cache: HIT X-Frame-Options: SAMEORIGIN Allow-Ranges: bytes Content-Security-Policy: frame-ancestors 'self' continuum.epublishing.com *.continuum.epublishing.com HTTP/1.1 200 OK Server: nginx Date: Wed, 20 Oct 2021 13:56:51 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive Vary: Accept-Encoding X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff ETag: W/"db14ebd8ddcfec6d64f780bbc58d57dd" Cache-Control: max-age=0, private, must-revalidate, private Strict-Transport-Security: max-age=31536000 Age: 237 Via: 1.1 varnish Vary: Accept-Encoding, User-Agent X-Cache: HIT X-Frame-Options: SAMEORIGIN Allow-Ranges: bytes Content-Security-Policy: frame-ancestors 'self' continuum.epublishing.com *.continuum.epublishing.com |
bioworld.com Whois Information
Domain Name: BIOWORLD.COM Registry Domain ID: 1173455_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-01-11T10:09:54Z Creation Date: 1997-02-11T05:00:00Z Registry Expiry Date: 2022-02-12T05:00:00Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: HA1.MARKMONITOR.ZONE Name Server: HA2.MARKMONITOR.ZONE Name Server: HA3.MARKMONITOR.ZONE Name Server: HA4.MARKMONITOR.ZONE DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T03:26:03Z <<< |